Oncology Pharma Inc. (OTCPK:ONPH) signed a Letter of Intent to acquire 50% stake in Diagnomics, Inc. on December 11, 2019. Included in the acquisition is Diagnomics' partial of minority stake in EONE-Diagnomics Genome Center in Seoul South Korea. As on December 23, 2019, as part of the transaction, Onco Pharma will acquire a 5% interest of India-Eone Diagnomics center and also include a 3.25% stake in Eone Diagnomics of South Korea. Oncology Pharma Inc. (OTCPK:ONPH) cancelled the acquisition of acquire 50% stake in Diagnomics, Inc. on December 11, 2020.